Concepedia

Andrew Fedoriw

AF

13

Publications

1.3K

Citations

13

H-Index

1998

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

University of Pennsylvania

GlaxoSmithKline (United States)

UNC Lineberger Comprehensive Cancer Center

Andrew Fedoriw is an author at University of North Carolina at Chapel Hill specializing in medicine, cell biology, and chromatin.

Top concepts

Publications per year

1998–2022

13

Publications

13

Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss

Andrew Fedoriw, Satyajit Rajapurkar, Shane W. O’Brien et al. · Cancer Cell · 2019 · 333 citations · Full text

, , +10

Transgenic RNAi Reveals Essential Function for CTCF in <i>H19</i> Gene Imprinting

Andrew Fedoriw, Paula Stein, Petr Svoboda et al. · Science · 2004 · 291 citations

Maternal depletion of CTCF reveals multiple functions during oocyte and preimplantation embryo development

Le-Ben Wan, Hua Pan, Sridhar Hannenhalli et al. · Development · 2008 · 142 citations · Full text

, , +20

Genomic Imprinting and Epigenetic Control of Development

Andrew Fedoriw, Joshua W. Mugford, Terry Magnuson · Cold Spring Harbor Perspectives in Biology · 2012 · 123 citations · Full text

Repression of the soma-specific transcriptome by Polycomb-repressive complex 2 promotes male germ cell development

Weipeng Mu, Joshua Starmer, Andrew Fedoriw et al. · Genes & Development · 2014 · 109 citations · Full text

, , +26

Rows per page

1–5 of 13